Unlike HMGCR, where SNPs in the locus reduce LDL-C and CAD risk yet increase glycemic burden, SLC22A3 SNPs reduce all three traits (LDL-C, CAD risk and glycemic burden). Here, HMGCR is linked to coronary artery disorder.